Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin

Journal of Microbiology, Immunology and Infection

Volumn 40, Issue 6, 2007, Pages 537-540

  Ho, Yu Huai ^a   Wang, Lih Shinn ^a   Chao, Hui Jen ^a   Chang, Kia Chich ^a   Su, Chain Fa ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Acinetobacter baumannii; Colistin; Drug resistance, multiple; Injections, spinal; Meningitis, bacterial

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; COLISTIN; FLOMOXEF; MEROPENEM; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER INVASION; CANCER SURGERY; CASE REPORT; CEREBROSPINAL FLUID; DISEASE DURATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; MENINGIOMA; MENINGITIS; POSTOPERATIVE INFECTION; SALVAGE THERAPY; TREATMENT DURATION; TREATMENT RESPONSE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CEREBROSPINAL FLUID; COLISTIN; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SPINAL; MENINGEAL NEOPLASMS; MENINGIOMA; MENINGITIS, BACTERIAL; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 40649106691     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin Microbiol Rev. 1996;9:148-65.
2. Go ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano N, et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet. 1994;344:1329-32.
3. Kuo LC, Teng LJ, Yu CJ, Ho SW, Hsueh PR. Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol. 2004;42:1759-63.
4. Benedict RG, Langlykke AF. Antibiotic activity of Bacillus polymyxa. J Bacteriol. 1947;54:24-5.
5. Ross S, Puig JR, Zaremba EA. Colistin: some preliminary laboratory and clinical observations in specific gastroenteritis in infants and children. Antibiot Annu. 1959-1960;7:89-100.
6. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40:1333-41.
7. Horton J, Pankey GA. Polymyxin B, colistin, and sodium colistimethate. Med Clin North Am. 1982;66:135-42.
8. Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother. 1999;33:960-7.
9. Katragkou A, Roilides E. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin. J Clin Microbiol. 2005;43:4916-7.
10. Benifla M, Zucker G, Cohen A, Alkan M. Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E. J Antimicrob Chemother. 2004;54:290-2.
11. Fernandez-Viladrich P, Corbella X, Corral L, Tubau F, Mateu A. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis. 1999;28:916-7.
12. Vasen W, Desmery P, Ilutovich S, Di Martino A. Intrathecal use of colistin. J Clin Microbiol. 2000;38:3523.
13. Kasiakou SK, Rafailidis PI, Liaropoulos K, Falagas ME. Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin. J Infect. 2005;50:348-52.
14. Schina M, Spyridi E, Daoudakis M, Mertzanos E, Korfias S. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin. Int J Infect Dis. 2006;10:178-9.